Company Profiles

driven by the PitchBook Platform

Principia Biopharma

Description

Developer of drugs for cancer and immune diseases. The company focuses on the design and development of small molecule drugs.

2008

Founded

PRIVATE

Status

11-50

Employees

Series B3

Latest Deal Type

$15.3M

Latest Deal Amount

$102M

Total Amount Raised

Description

Developer of drugs for cancer and immune diseases. The company focuses on the design and development of small molecule drugs.

Website:

www.principiabio.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Primary Office

400 East Jamie Court Suite 302 South South San Francisco, CA 94080United States +1 (650) 416-7700
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Principia Biopharma's full profile, request a free trial.

Principia Biopharma Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Principia Biopharma Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Principia Biopharma Investors (7)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Lightstone VenturesVenture CapitalMinority000 0000000 0000
Mission Bay CapitalVenture CapitalMinority000 0000000 0000
MorgenthalerVenture CapitalMinority000 0000000 0000
New Leaf Venture PartnersVenture CapitalMinority000 0000000 0000
OrbiMedVenture CapitalMinority000 0000000 0000
Lightstone Ventures Venture Capital
Mission Bay Capital Venture Capital
Morgenthaler Venture Capital
New Leaf Venture Partners Venture Capital
OrbiMed Venture Capital

Principia Biopharma Executive Team (8)

NameTitleBoard
Seat
Contact
Info
Martin BablerChief Executive Officer, President & Board Member
Christopher ChaiChief Financial Officer
Jens Funk MDChief Scientific Officer
Roy Hardiman JDChief Business Officer
Ken Brameld Ph.DExecutive Director, Computational Chemistry
Martin Babler Chief Executive Officer, President & Board Member
Christopher Chai Chief Financial Officer
Jens Funk MD Chief Scientific Officer
Roy Hardiman JD Chief Business Officer
Ken Brameld Ph.D Executive Director, Computational Chemistry

Principia Biopharma Board Members (8)

NameRepresentingRoleSinceContact
Info
Jack Taunton Ph.DSelfBoard Observer000 0000
Lewis ShusterSelfDirector000 0000
Martin BablerPrincipia BiopharmaChief Executive Officer, President & Board Member000 0000
Michael Dybbs Ph.DNew Leaf Venture PartnersConsultant000 0000
Nassim Usman Ph.DMorgenthalerVenture Partner, Life Sciences000 0000
Jack Taunton Ph.D Board Observer Self
Lewis Shuster Director Self
Martin Babler Chief Executive Officer, President & Board Member Principia Biopharma
Michael Dybbs Ph.D Consultant New Leaf Venture Partners
Nassim Usman Ph.D Venture Partner, Life Sciences Morgenthaler
Request full access to PitchBook